Cipla shares rally on anti-asthma inhaler launch in Germany

Posted By:
Subscribe to GoodReturns

Shares in Cipla jumped sharply by 7 per cent after the pharma major launched an anti-asthma inhaler in Germany and Sweden. the stock was last trading at Rs 564 on the Bombay Stock Exchange.

The inhaler is a generic version of GlaxoSmithKline Plc's Advair.

Noted broking firm, Emkay Global upgraded the stock to "buy" from "accumulate" with a target of 671 rupees.

Overall addressable opportunity of generic Advair is $800 million in Europe, Emkay said.

Cipla shares were trading up 7.1 percent to 566.75 rupees as of 10:02 a.m.

Read more about: cipla
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?